Ultrasound contrast agents: Substance classes, pharmacokinetics, clinical indications, safety profile;Ultraschallkontrastmittel: Substanzklassen, pharmakokinetik, klinische anwendungen, sicherheitsaspekte

Radiologe

Volumn 45, Issue 6, 2005, Pages 513-519

  Krestan, C ^a  

^a UNIV KLIN FÜR RADIODIAGNOSTIK   (Austria)

Author keywords

Classes; Clinical indications; Pharmacokinetics; Safety profile

Indexed keywords

ECHO CONTRAST MEDIUM; ECHOVIST; FS 069; PERFLEXANE; PERFLUTREN; SHU 508; SONOVUE; CONTRAST MEDIUM;

ACOUSTICS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; DRUG SAFETY; DRUG STABILITY; ECHOGRAPHY; EMBOLISM; KIDNEY INJURY; PSEUDOTUMOR; REVIEW; TREATMENT INDICATION; BIOLOGICAL MODEL; CLASSIFICATION; CLINICAL PRACTICE; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; MICROBUBBLE; PRACTICE GUIDELINE;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; MICROBUBBLES; MODELS, BIOLOGICAL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; ULTRASONOGRAPHY;

EID: 21744455714     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-005-1191-4     Document Type: Review

References (60)

1. Albrecht T, Urbank A, Mahler M et al. (1998) Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience. Radiology 207: 339-347
2. Albrecht T, Blomley MJ, Cosgrove DO et al. (1999) Transit-time studies with levovist in patients with and without hepatic cirrhosis: a promising new diagnostic tool. Eur Radiol 9 [Suppl 3]: S377-381
3. Albrecht T, Hoffmann CW, Schmitz SA et al. (2001) Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR Am J Roentgenol 176: 1191-1198
4. Albrecht T, Blomley M, Bolondi L et al. (2004) Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 25: 249-256
5. Albrecht T, Hohmann J, Oldenburg A, Skrok J, Wolf KJ (2004) Detection and characterization of liver metastases. Eur Radiol 14 [Suppl 8]: P25-33
6. Argalia G, De Bernardis S, Mariani D et al. (2002) Ultrasonographic contrast agent: evaluation of time-intensity curves in the characterization of solitary thyroid nodules. Radiol Med (Torino) 103: 407-413
7. Ascenti G, Zimbaro G, Mazziotti S, Gaeta M, Settineri N, Scribano E (2001) Usefulness of power Doppler and contrast-enhanced sonography in the differentiation of hyperechoic renal masses. Abdom Imaging 26: 654-660
8. Ascenti G, Zimbaro G, Mazziotti S, Gaeta M, Lamberto S, Scribano E (2001) Contrast-enhanced power Doppler US in the diagnosis of renal pseudotumors. Eur Radiol 11: 2496-2499
9. Ascenti G, Zimbaro G, Mazziotti S et al. (2004) Harmonic US imaging of vesicoureteric reflux in children: usefulness of a second generation US contrast agent. Pediatr Radiol 34: 481-487
10. Barr R (2002) Seeking consensus: contrast ultrasound in radiology. Eur J Radiol 41: 207-216
11. Bauer A, Solbiati L, Weissman N (2002) Ultrasound imaging with SonoVue: low mechanical index real-time imaging. Acad Radiol 9 [Suppl 2]: S282-284
12. Bendick PJ, Bove PG, Long GW, Zelenock GB, Brown OW, Shanley CJ (2003) Efficacy of ultrasound scan contrast agents in the noninvasive follow-up of aortic stent grafts. J Vasc Surg 37: 381-385
13. Blomley MJ, Albrecht T, Cosgrove DO et al. (1999) Stimulated acoustic emission to image a late liver and spleen-specific phase of levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 25: 1341-1352
14. Brenner DJ, Elliston CD (2004) Estimated radiation risks potentially associated with full-body CT screening. Radiology 232: 735-738
15. Carroll BA, Turner RJ, Tickner EG, Boyle DB, Young SW (1980) Gelatin encapsulated nitrogen microbubbles as ultrasonic contrast agents. Invest Radiol 15: 260-266
16. Correas JM, Burns PN, Lai X, Qi X (2000) Infusion versus bolus of an ultrasound contrast agent: in vivo dose-response measurements of BR1. Invest Radiol 35: 72-79
17. Cosgrove D (2004) Future prospects for SonoVue and CPS. Eur Radiol 14 [Suppl 8]: P116-124
18. Cosgrove D (2004) The advances are significant improvements in both the microbubbles used as contrast agents and in the software that allows their selective detection. Eur Radiol 14 [Suppl 8]: P1-3
19. Darge K, Moeller RT, Trusen A, Butter F, Gordjani N, Riedmiller H (2005) Diagnosis of vesicoureteric reflux with low-dose contrast-enhanced harmonic ultrasound imaging. Pediatr Radiol 35: 73-78
20. Dietrich CF (2002) 3D real time contrast enhanced ultrasonography, a new technique. Rofo 174: 160-163
21. EMEA (2004) Sonovue - new contraindications in patients with heart disease. CPMP 212: 1-5
22. Feinstein SB, Ten Cate FJ, Zwehl W et al. (1984) Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol 3: 14-20
23. Fritzsch T, Schartl M, Siegert J (1988) Preclinical and clinical results with an ultrasonic contrast agent. Invest Radiol 23 [Suppl 1]: S302-305
24. Giannoni MF, Palombo G, Sbarigia E, Speziale F, Zaccaria A, Fiorani P (2003) Contrast-enhanced ultrasound imaging for aortic stent-graft surveillance. J Endovasc Ther 10: 208-217
25. Goldberg BB (1976) Ultrasonic cholangiography. Gray-scale B-scan evaluation of the common bile duct. Radiology 118: 401-404
26. Goldberg BB, Merton DA, Liu JB et al. (2004) Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 230: 727-734
27. Greis C (2004) Technology overview: SonoVue (Bracco, Milan). Eur Radiol 14 [Suppl 8]: P11-15
28. Haggag KJ, Russell D, Walday P, Skiphamn A, Torvik A (1998) Air-filled ultrasound contrast agents do not damage the cerebral microvasculature or brain tissue in rats. Invest Radiol 33: 129-135
29. Huber S, Helbich T, Kettenbach J, Dock W, Zuna I, Delorme S (1998) Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US - early experience. Radiology 208: 485-489
30. Hutter JC, Luu HM, Mehlhaff PM, Killam AL, Dittrich HC (1999) Physiologically based pharmacokinetic model for fluorocarbon elimination after the administration of an octafluoropropane-albumin microsphere sonographic contrast agent. J Ultrasound Med 18: 1-11
31. Kim JH, Eun HW, Lee HK et al. (2003) Renal perfusion abnormality. Coded harmonic angio US with contrast agent. Acta Radiol 44: 166-171
32. Koike H, Tomita N, Azuma H et al. (2005) An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 7: 108-116
33. 32a. Kono Y, Pinell SP, SirLin CB et al. (2004) Carotid arteries: contrast-enhanced US angiography-preliminary clinical experience. Radiology 230: 561-568
34. Kopitzko A, Cornely D, Reither K, Wolf KJ, Albrecht T (2004) Low contrast dose voiding urosonography in children with phase inversion imaging. Eur Radiol 14: 2290-2296
35. Krestan CR, Riedl C, Memarsadeghi M, Rudas M, Pfarl G, Helbich TH (2002) 3D-power Doppler ultrasound of breast lesions with a microbubble contrast agent. Acad Radiol 9 [Suppl 2]: S384-385
36. Krestan CR, Herneth AM, Niederle B, Weber M, Imhof H, Czerny C (2004) Pulse-inversion harmonic contrast imaging after i.v. administration of sonovue for differentiation of benign and malignant thyroid nodules. Radiol Soc North Am
37. Lim AK, Patel N, Eckersley RJ, Taylor-Robinson SD, Cosgrove DO, Blomley MJ (2004) Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers. Radiology 231: 785-788
38. Marshall M, Halligan S, Eckersley RJ et al. (2005) A novel technique to measure splanchnic transit time using microbubble ultrasound. Invest Radiol 40: 80-84
39. Martegani A, Aiani L, Borghi C (2004) The use of contrast-enhanced ultrasound in large vessels. Eur Radiol 14 [Suppl 8]: P73-86
40. Mattrey RF, Leopold GR, van Sonnenberg E, Gosink BB, Scheible FW, Long DM (1983) Perfluorochemicals as liver- and spleen-seeking ultrasound contrast agents. J Ultrasound Med 2: 173-176
41. Napoli V, Bargellini I, Sardella SG et al. (2004) Abdominal aortic aneurysm: contrast-enhanced US for missed endoleaks after endoluminal repair. Radiology 233: 217-225
42. Oldenburg A, Hohmann J, Skrok J, Albrecht T (2004) Imaging of paediatric splenic injury with contrast-enhanced ultrasonography. Pediatr Radiol 34: 351-354
43. Phillips P, Gardner E (2004) Contrast-agent detection and quantification. Eur Radiol 14 [Suppl 8]: P4-10
44. Poletti PA, Platon A, Becker CD et al. (2004) Blunt abdominal trauma: does the use of a second-generation sonographic contrast agent help to detect solid organ injuries? AJR Am J Roentgenol 183: 1293-1301
45. Price RJ, Kaul S (2002) Contrast ultrasound targeted drug and gene delivery: an update on a new therapeutic modality. J Cardiovasc Pharmacol Ther 7: 171-180
46. Radmayr C, Oswald J, Klauser A, Bartsch G, Frauscher F (2002) Contrast-medium enhanced reflux ultrasound in children. A comparison with radiologic imaging up to now. Urologe A-41: 548-551
47. Schlief R, Schurmann R, Niendorf HP (1996) Bloodpool echo enhancement after intravenous injection of galactose-based microbubbles: results from European phase III clinical trials in Doppler sonography. Acad Radiol 3 [Suppl 2]: S466-467
48. Schneider M (1999) Characteristics of SonoVuetrade mark. Echocardiography 16: 743-746
49. Schneider M, Arditi M, Barrau MB et al. (1995) BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 30: 451-457
50. Uchimoto R, Niwa K, Eguchi H et al. (1999) In vivo kinetics of microbubbles of SH U 508 A (Levovist): comparison with indocyanine green in rabbits. Ultrasound Med Biol 25: 1365-1370
51. Unger EC, McCreery TP, Sweitzer RH, Caldwell VE, Wu Y (1998) Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 33: 886-892
52. Valentini AL, De Gaetano AM, Minordi LM et al. (2004) Contrast-enhanced voiding US for grading of reflux in adult patients prior to antireflux ureteral implantation. Radiology 233: 35-39
53. Vassiou K, Vlychou M, Moisidou R, Sioka A, Fezoulidis IV (2004) Contrast-enhanced sonographic detection of vesicoureteral reflux in children: comparison with voiding cystourethrography. Rofo 176: 1453-1457
54. Wedegartner U, Lorenzen M, Nagel HD, Weber C, Adam G (2004) Diagnostic imaging in polytrauma: comparison of radiation exposure from whole-body MSCT and conventional radiography with organ-specific CT. Rofo 176: 1039-1044
55. Wei K, Le E, Bin JP, Coggins M, Thorpe J, Kaul S (2001) Quantification of renal blood flow with contrast-enhanced unltrasound. J Am Coll Cardil 37: 1135-1140
56. Yang WT, Metreweli C, Lam PK, Chang J (2001) Benign and malignant breast masses and axillary nodes: evaluation with echo-enhanced color power Doppler US. Radiology 220: 795-802
57. Yucel C, Ozdemir H, Akpek S, Gurel K, Kapucu LO, Arac M (2001) Renal infarct: contrast-enhanced power Doppler sonographic findings. J Clin Ultrasound 29: 237-242
58. Zachary JF, Hartleben SA, Frizzell LA, O'Brien WD Jr (2002) Arhythmias in rat hearts exposed to pulsed ultrasound after intravenous injection of a contrast agent. J Ultrasound Med 21: 1347-1356; discussion 1343-1345
59. Zdemir A, Kilic K, Ozdemir H, Yucel C, Andac S, Colak M (2004) Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography. J Ultrasound Med 23: 183-195; quiz 196-187
60. Becher P, Burns PN (2000) Handbook of contrast echocardiography. Springer, Berlin Heidelberg New York